Priority Date: 14.12.11 (US 201161570593P)

HUMAN MONOCYTE SUB-POPULATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM INJURY

  • Application ID: EP12858248
  • Status: PATENT GRANTED

Applicant

Company dna yeda research and development co ltd
Technology Transfer Office

Attorney

Company dna brevalex
no operation time available
1026.07
1 office
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB and 171 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 14.12.2011 - Priority Date (US 201161570593P)
  • 20.06.2013 - Publication A1 (WO2013088441)
  • 22.10.2014 - Publication A1 (EP2790712)
  • 31.08.2016 - Publication B1 (EP2790712)

IPC Classification